Seven

Major depression is one of the most common mental disorders in the U.S. Approximately 7% (17.3 million) of American adults had at least one major depressive episode in 2017. Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any… Read More

SUBMISSION DEADLINE EXTENDED TO JULY 18! The Cell Imaging Shared Resource is hosting its second annual Life Is Beautiful Image Contest. The contest, which features stunning scientific imagery of the inherent beauty of life at the microscopic level, is open to anyone who has captured an image… Read More

Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics, has been named senior associate dean for research for the School of Medicine Basic Sciences. He succeeds Chuck Sanders, who will transition from vice dean to a new role as senior advisor to the dean, effective July… Read More

Since its publication on February 21, 2025, the Burnette Lab’s article detailing the discovery of blebbisomes—a newly identified class of extracellular vesicles—has received over 44,000 Article Accesses, a remarkable benchmark for scientific reach and engagement. This visibility is due in part to Vanderbilt University’s new open access agreement with… Read More

A leading chemical biologist working on ribosomally synthesized and post-translationally modified peptides, Doug Mitchell has joined the School of Medicine Basic Sciences as the William Kelly Warren Sr. Professor of Biochemistry and director of the Vanderbilt Institute for Chemical Biology. He also has been named professor of chemistry. Read More

Researchers from the Warren Center for Neuroscience Drug Discovery, in collaboration with Boehringer Ingelheim, developed a compound that can treat both negative and positive symptoms of schizophrenia in rodents. The compound holds promise as an investigational tool and an inspiration for novel schizophrenia therapies. Read More

Lisa M. Monteggia and Matthew J. Tyska are among the 471 scientists elected as 2024 fellows of the American Association for the Advancement of Science. Dean John Kuriyan was also recently elected a member of the 2025 class of fellows of the American Association for Cancer Research academy. Read More

“This transformative agreement allows Vanderbilt researchers to benefit from Nature’s tremendous influence and reach,” University Librarian Jon Shaw said. “Our research findings will reach global audiences immediately upon publication, speeding up scientific innovation and progress. This collaboration not only strengthens Vanderbilt’s reputation but will aid in attracting top faculty, students and partnerships to the university.” Read More

Vanderbilt-affiliated authors may publish their original research articles APC-free in JAMA Network journals through a Creative Commons license. Twelve of the network’s journals—including JAMA Internal Medicine, JAMA Neurology and JAMA Oncology—are ranked in the top quartile of their respective subject areas. Read More

Great Britain’s Wellcome Trust has recognized Vanderbilt’s Carrie K. Jones and the University of Glasgow’s Andrew Tobin with their prestigious Discovery Award. The pair will study how blocking the M5 muscarinic receptor in the brain counteracts opioids’ addictive properties, which could lead to new treatments for preventing or addressing opioid addiction. Read More